Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates [Yahoo! Finance]
Fennec Pharmaceuticals Inc. (FENC)
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.fennecpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
The results were impressive, with revenues of US$6.5m exceeding analyst forecasts by 22%, and statutory losses of US$0.07 were likewise much smaller than the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. Taking into account the latest results, the most recent consensus for Fennec Pharmaceuticals from six analysts is for revenues of US$44.0m in 2024. If met, it would imply a huge 237% increase on its revenue over the past 12 months. Fennec Pharmaceuticals is also expected to turn profitable, with statutory earnings of US$0.23 per share. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$41.4m and earnings per share (EPS) of US$0.13 in 2024. So i
Show less
Read more
Impact Snapshot
Event Time:
FENC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FENC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FENC alerts
High impacting Fennec Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
FENC
News
- Southpoint sells $7.5M worth stock of Fennec Pharmaceuticals [Seeking Alpha]Seeking Alpha
- Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) [Yahoo! Finance]Yahoo! Finance
- Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC)GlobeNewswire
- Fennec Pharmaceuticals: A Compelling Single-Asset Growth Story For 2026 [Seeking Alpha]Seeking Alpha
- Adherex Technologies (NASDAQ:FENC) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
FENC
Earnings
- 11/13/25 - Beat
FENC
Sec Filings
- 12/9/25 - Form 8-K
- 12/5/25 - Form 4
- 12/5/25 - Form 144
- FENC's page on the SEC website